Le Lézard
Classified in: Health
Subjects: PDT, FDA, PLW, MAT

New Vapor Cartridge Technology Promises to Replace All Vape Pens and Handheld Vaporizers


Cheaper, safer and more convenient

STILLWATER, Minn., Oct. 24, 2022 /PRNewswire/ -- Vapor Cartridge Technology LLC, based in historic Stillwater Minnesota, has invented, and patented a groundbreaking technology that portends the power to truly change the entire cannabis industry. Vapor Cartridge Technology LLC has invented and patented an FDA approvable, environmentally friendly, cost-effective process, for extracting the essential oils/resins from botanical plants (e.g., cannabis) and an FDA approvable device for delivering a pure and exact dose of the extracted oils/resins as a consistently reliable precise inhalable vapor.

It promises to be, far and away, the most cost-efficient manner to deliver cannabinoid vapors as measured by $/mg/ml of cannabinoids in the bloodstream. It promises to be the only technology that can provide the dose control, formulation control and purity assurance of inhaled botanical vapors required of an FDA approved drug. This technology will result in a paradigm shift in both the Medical and Recreational cannabis markets.

"Once commercialized The Vapor Cartridge Technology will quickly become the standard for ingesting cannabinoid drugs in vapor form, replacing vape pens and handheld vaporizers. Our company's website (( https://vaporcartridgetechnology.com )) provides the technical and business data supporting these claims," according to a spokesperson for the company.

Vapor Cartridge Technology LLC is currently seeking licensing opportunities for their new technology.  Their compelling website contains a detailed explanation of the science behind the technology, a competitive analysis, the benefits of the technology, the patent portfolio, potential licensees, and a way to contact the company.

Media Contact

Timothy L. McCullough
Vapor Cartridge Technology LLC
Owner

044 Oak Glen Drive
Stillwater, MN 55082

Mobile 651-491-2115
E-Mail: [email protected] 

SOURCE Vapor Cartridge Technology LLC


These press releases may also interest you

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

3 jui 2024
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: